FLGT logo

Fulgent Genetics (FLGT) Cash From Investing

Annual CFI

-$58.35 M
-$97.25 M-250.01%

December 31, 2024

Summary

Performance

1-Year Change

-250.01%

3-Year Change

+89.32%

5-Year Change

-100.9%

15-Year Change

-2747.83%

FLGT Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

21.31%
FLGT annual cash flow from investing activities is higher than 21.31% of companies in Healthcare sector

High & Low

All-time High

$38.90 M
FLGT annual cash flow from investing activities is currently -250.01% below its historical high of $38.90 million

3-Year Low

-$546.55 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
FLGT previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
FLGT next annual earnings announcement has not yet been scheduled

OtherFLGTcash flowmetrics:

Annual CFF

-$4.85 M
FLGT annual cash flow from financing activities is -$4.85 million

Annual CFO

$21.06 M
FLGT annual cash flow from operations is $21.06 million

Annual FCF

-$19.25 M
FLGT annual free cash flow is -$19.25 million

Annual CAPEX

$40.31 M
FLGT annual capital expenditures is $40.31 million

Quarterly CFI

-$27.45 M
-$36.44 M-405.56%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

+23.9%

FLGT Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

16.05%
FLGT quarterly cash flow from investing activities is higher than 16.05% of companies in Healthcare sector

High & Low

All-time High

$44.29 M
FLGT quarterly cash flow from investing activities is currently -161.99% below its historical high of $44.29 million

3-Year Low

-$213.69 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
FLGT previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
FLGT next earnings announcement is scheduled for May 2, 2025

OtherFLGTcash flowmetrics:

Quarterly CFF

-$327.00 K
FLGT quarterly cash flow from financing activities is -$327.00 thousand

Quarterly CFO

$25.02 M
FLGT quarterly cash flow from operations is $25.02 million

Quarterly FCF

$21.24 M
FLGT quarterly free cash flow is $21.24 million

Quarterly CAPEX

$3.78 M
FLGT quarterly capital expenditures is $3.78 million

TTM CFI

-$58.35 M
-$51.73 M-780.52%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

-100.9%

FLGT TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

22.97%
FLGT TTM cash flow from investing activities is higher than 22.97% of companies in Healthcare sector

High & Low

All-time High

$38.90 M
FLGT TTM cash flow from investing activities is currently -250.01% below its historical high of $38.90 million

3-Year Low

-$546.55 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
FLGT previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
FLGT next earnings announcement is scheduled for May 2, 2025

OtherFLGTcash flowmetrics:

TTM CFF

-$4.85 M
FLGT TTM cash flow from financing activities is -$4.85 million

TTM CFO

$21.06 M
FLGT TTM cash flow from operations is $21.06 million

TTM FCF

-$19.25 M
FLGT TTM free cash flow is -$19.25 million

TTM CAPEX

$40.31 M
FLGT TTM capital expenditures is $40.31 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

FLGT Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-250.0%0.0%0.0%
3 y3 years+89.3%0.0%0.0%
5 y5 years-100.9%+23.9%-100.9%

FLGT Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-250.0%+89.3%-162.0%+87.2%-250.0%+89.3%
5 y5-year-250.0%+89.3%-162.0%+91.4%-250.0%+92.0%
alltimeall time-250.0%+89.3%-162.0%+91.4%-250.0%+92.0%

Fulgent Genetics Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-$58.35 M(-250.0%)
-$27.45 M(-405.6%)
-$58.35 M(+780.5%)
Sep 2024
-
$8.98 M(+23.0%)
-$6.63 M(-248.4%)
Jun 2024
-
$7.30 M(-115.5%)
$4.47 M(-213.5%)
Mar 2024
-
-$47.19 M(-294.4%)
-$3.93 M(-110.1%)
Dec 2023
$38.90 M(-114.9%)
$24.27 M(+20.9%)
$38.90 M(-149.9%)
Sep 2023
-
$20.08 M(-1931.9%)
-$77.97 M(+45.0%)
Jun 2023
-
-$1.10 M(-74.8%)
-$53.76 M(-79.8%)
Mar 2023
-
-$4.35 M(-95.3%)
-$266.36 M(+1.9%)
Dec 2022
-$261.31 M(-52.2%)
-$92.60 M(-309.1%)
-$261.31 M(-15.4%)
Sep 2022
-
$44.29 M(-120.7%)
-$308.97 M(-20.4%)
Jun 2022
-
-$213.69 M(<-9900.0%)
-$388.06 M(+17.8%)
Mar 2022
-
$688.00 K(-100.5%)
-$329.37 M(-39.7%)
Dec 2021
-$546.55 M(+67.4%)
-$140.26 M(+303.1%)
-$546.55 M(-24.6%)
Sep 2021
-
-$34.79 M(-77.6%)
-$725.06 M(+4.8%)
Jun 2021
-
-$155.00 M(-28.4%)
-$691.67 M(+28.3%)
Mar 2021
-
-$216.49 M(-32.1%)
-$539.07 M(+65.1%)
Dec 2020
-$326.44 M
-$318.77 M(>+9900.0%)
-$326.44 M(+646.1%)
Sep 2020
-
-$1.40 M(-41.6%)
-$43.75 M(+21.5%)
Jun 2020
-
-$2.40 M(-37.7%)
-$36.00 M(+18.5%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$3.86 M(-89.3%)
-$30.39 M(+4.6%)
Dec 2019
-$29.05 M(-3157.5%)
-$36.08 M(-668.7%)
-$29.05 M(-745.9%)
Sep 2019
-
$6.34 M(+97.6%)
$4.50 M(+44.4%)
Jun 2019
-
$3.21 M(-227.3%)
$3.12 M(-291.9%)
Mar 2019
-
-$2.52 M(-0.6%)
-$1.62 M(-270.8%)
Dec 2018
$950.00 K(-146.4%)
-$2.54 M(-151.1%)
$950.00 K(-44.9%)
Sep 2018
-
$4.96 M(-425.0%)
$1.72 M(-129.7%)
Jun 2018
-
-$1.53 M(-3094.1%)
-$5.81 M(+4436.7%)
Mar 2018
-
$51.00 K(-102.9%)
-$128.00 K(-93.8%)
Dec 2017
-$2.05 M(-95.2%)
-$1.76 M(-31.3%)
-$2.05 M(-94.8%)
Sep 2017
-
-$2.57 M(-161.8%)
-$39.70 M(-0.6%)
Jun 2017
-
$4.15 M(-322.0%)
-$39.95 M(-10.2%)
Mar 2017
-
-$1.87 M(-95.3%)
-$44.49 M(+4.0%)
Dec 2016
-$42.80 M(+1840.8%)
-$39.42 M(+1299.7%)
-$42.80 M(+1166.5%)
Sep 2016
-
-$2.82 M(+629.5%)
-$3.38 M(+500.2%)
Jun 2016
-
-$386.00 K(+118.1%)
-$563.00 K(+218.1%)
Mar 2016
-
-$177.00 K
-$177.00 K
Dec 2015
-$2.21 M(+182.7%)
-
-
Dec 2014
-$780.00 K
-
-

FAQ

  • What is Fulgent Genetics annual cash flow from investing activities?
  • What is the all time high annual CFI for Fulgent Genetics?
  • What is Fulgent Genetics annual CFI year-on-year change?
  • What is Fulgent Genetics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Fulgent Genetics?
  • What is Fulgent Genetics quarterly CFI year-on-year change?
  • What is Fulgent Genetics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Fulgent Genetics?
  • What is Fulgent Genetics TTM CFI year-on-year change?

What is Fulgent Genetics annual cash flow from investing activities?

The current annual CFI of FLGT is -$58.35 M

What is the all time high annual CFI for Fulgent Genetics?

Fulgent Genetics all-time high annual cash flow from investing activities is $38.90 M

What is Fulgent Genetics annual CFI year-on-year change?

Over the past year, FLGT annual cash flow from investing activities has changed by -$97.25 M (-250.01%)

What is Fulgent Genetics quarterly cash flow from investing activities?

The current quarterly CFI of FLGT is -$27.45 M

What is the all time high quarterly CFI for Fulgent Genetics?

Fulgent Genetics all-time high quarterly cash flow from investing activities is $44.29 M

What is Fulgent Genetics quarterly CFI year-on-year change?

Over the past year, FLGT quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Fulgent Genetics TTM cash flow from investing activities?

The current TTM CFI of FLGT is -$58.35 M

What is the all time high TTM CFI for Fulgent Genetics?

Fulgent Genetics all-time high TTM cash flow from investing activities is $38.90 M

What is Fulgent Genetics TTM CFI year-on-year change?

Over the past year, FLGT TTM cash flow from investing activities has changed by $0.00 (0.00%)